These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 9734710)

  • 21. Genistein, a phytoestrogen, attenuates monocrotaline-induced pulmonary hypertension.
    Homma N; Morio Y; Takahashi H; Yamamoto A; Suzuki T; Sato K; Muramatsu M; Fukuchi Y
    Respiration; 2006; 73(1):105-12. PubMed ID: 16432296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Defective intracellular calcium handling in monocrotaline-induced right ventricular hypertrophy: protective effect of long-term endothelin-A receptor blockade with 2-benzo[1,3]dioxol-5-yl-3-benzyl-4-(4-methoxy-phenyl-)- 4-oxobut-2-enoate-sodium (PD 155080).
    Brunner F; Wölkart G; Haleen S
    J Pharmacol Exp Ther; 2002 Feb; 300(2):442-9. PubMed ID: 11805203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Type V phosphodiesterase inhibition modulates endogenous immunoreactivities of endothelin-1 and endothelial nitric oxide synthase in pulmonary arteries in rats with monocrotaline-induced pulmonary hypertension.
    Takahashi T; Kanda T; Sumino H; Inoue M; Sato K; Sakamaki T; Kobayashi I; Iwamoto A; Nagai R
    Res Exp Med (Berl); 1998 Apr; 197(6):319-28. PubMed ID: 9638794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulmonary Artery Hypertension Model in Rats by Monocrotaline Administration.
    Bueno-Beti C; Sassi Y; Hajjar RJ; Hadri L
    Methods Mol Biol; 2018; 1816():233-241. PubMed ID: 29987824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Roles of endothelin ETA and ETB receptors in the pathogenesis of monocrotaline-induced pulmonary hypertension.
    Nishida M; Eshiro K; Okada Y; Takaoka M; Matsumura Y
    J Cardiovasc Pharmacol; 2004 Aug; 44(2):187-91. PubMed ID: 15243299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulmonary artery remodeling differs in hypoxia- and monocrotaline-induced pulmonary hypertension.
    van Suylen RJ; Smits JF; Daemen MJ
    Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1423-8. PubMed ID: 9603118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of olmesartan medoxomil in the rat monocrotaline model of pulmonary hypertension.
    Kato T; Nasu T; Sonoda H; Ito KM; Ikeda M; Ito K
    J Cardiovasc Pharmacol; 2008 Jan; 51(1):18-23. PubMed ID: 18209564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiotensin converting enzyme activity and evolution of pulmonary vascular disease in rats with monocrotaline pulmonary hypertension.
    Kay JM; Keane PM; Suyama KL; Gauthier D
    Thorax; 1982 Feb; 37(2):88-96. PubMed ID: 6281933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
    Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
    Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac endothelin and big endothelin in right-heart hypertrophy due to monocrotaline-induced pulmonary hypertension in rat.
    Brunner F
    Cardiovasc Res; 1999 Oct; 44(1):197-206. PubMed ID: 10615403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pioglitazone alleviates cardiac and vascular remodelling and improves survival in monocrotaline induced pulmonary arterial hypertension.
    Behringer A; Trappiel M; Berghausen EM; Ten Freyhaus H; Wellnhofer E; Odenthal M; Blaschke F; Er F; Gassanov N; Rosenkranz S; Baldus S; Kappert K; Caglayan E
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):369-79. PubMed ID: 26742933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic efficacy of valproic acid in a combined monocrotaline and chronic hypoxia rat model of severe pulmonary hypertension.
    Lan B; Hayama E; Kawaguchi N; Furutani Y; Nakanishi T
    PLoS One; 2015; 10(1):e0117211. PubMed ID: 25629315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The orally active ET(A) receptor antagonist (+)-(S)-2-(4,6-dimethoxy-pyrimidin-2-yloxy)-3-methoxy-3,3-diphe nyl-propionic acid (LU 135252) prevents the development of pulmonary hypertension and endothelial metabolic dysfunction in monocrotaline-treated rats.
    Prié S; Leung TK; Cernacek P; Ryan JW; Dupuis J
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1312-8. PubMed ID: 9316840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of chymase-dependent angiotensin II formation in monocrotaline-induced pulmonary hypertensive rats.
    Kishi K; Jin D; Takai S; Muramatsu M; Katayama H; Tamai H; Miyazaki M
    Pediatr Res; 2006 Jul; 60(1):77-82. PubMed ID: 16690960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 2-Methoxyestradiol mediates the protective effects of estradiol in monocrotaline-induced pulmonary hypertension.
    Tofovic SP; Zhang X; Jackson EK; Dacic S; Petrusevska G
    Vascul Pharmacol; 2006 Dec; 45(6):358-67. PubMed ID: 16872912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DA-8159, a new PDE5 inhibitor, attenuates the development of compensatory right ventricular hypertrophy in a rat model of pulmonary hypertension.
    Kang KK; Ahn GJ; Sohn YS; Ahn BO; Kim WB
    J Int Med Res; 2003; 31(6):517-28. PubMed ID: 14708417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Attenuation of compensatory right ventricular hypertrophy and heart failure following monocrotaline-induced pulmonary vascular injury by the Na+-H+ exchange inhibitor cariporide.
    Chen L; Gan XT; Haist JV; Feng Q; Lu X; Chakrabarti S; Karmazyn M
    J Pharmacol Exp Ther; 2001 Aug; 298(2):469-76. PubMed ID: 11454907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PRX-08066, a novel 5-hydroxytryptamine receptor 2B antagonist, reduces monocrotaline-induced pulmonary arterial hypertension and right ventricular hypertrophy in rats.
    Porvasnik SL; Germain S; Embury J; Gannon KS; Jacques V; Murray J; Byrne BJ; Shacham S; Al-Mousily F
    J Pharmacol Exp Ther; 2010 Aug; 334(2):364-72. PubMed ID: 20430844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Semotiadil improves survival of rats with monocrotaline-induced pulmonary hypertension: comparison with diltiazem.
    Takahashi T; Kanda T; Imai S; Suzuki T; Kobayashi I; Murata K
    Eur J Pharmacol; 1996 Jan; 295(2-3):229-34. PubMed ID: 8720589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of rho kinase attenuates high flow induced pulmonary hypertension in rats.
    Li FH; Xia W; Li AW; Zhao CF; Sun RP
    Chin Med J (Engl); 2007 Jan; 120(1):22-9. PubMed ID: 17254483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.